Skip to content
naulon

Not checkedNot checked for notices yet.

News in Brief

Jack Williamson

The Lancet. Healthy Longevity · 2021

doi:10.1016/s2666-7568(21)00100-8 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

According to the National Cancer Institute, less than 3% of people who have cancer are considered eligible for enrolment in clinical research studies. Conventional measures for setting eligibility have been criticised as being overly restrictive, arbitrarily reusing criteria from previous trials or prioritising the inclusion of patients deemed to have low-risk profiles (eg, participants who are young, do not have severe disease, or do not have other comorbidities besides the condition of interest).

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.